Mueller Karin A L, Heck Christian, Heinzmann David, Schwille Johannes, Klingel Karin, Kandolf Reinhard, Kramer Ulrich, Gramlich Michael, Geisler Tobias, Gawaz Meinrad P, Schreieck Juergen, Seizer Peter
Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Universitaetsklinikum der Eberhard-Karls Universitaet, Tuebingen, Germany.
Abteilung für Molekulare Pathologie, Universitaetsklinikum der Eberhard-Karls Universitaet, Tuebingen, Germany.
PLoS One. 2016 Dec 8;11(12):e0167616. doi: 10.1371/journal.pone.0167616. eCollection 2016.
Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation.
We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ventricular tachycardia (VT) or fibrillation (VF) in programmed ventricular stimulation.
56 patients with impaired left ventricular ejection fraction (LVEF≤50%, mean 36.6±10.5%) due to non-ischemic dilated cardiomyopathy underwent cardiac MRI, programmed ventricular stimulation, and endomyocardial biopsy and were retrospectively investigated. Inducibility was defined as sustained mono- or polymorphic VT or unstable VT/VF requiring cardioversion/defibrillation. Primary study endpoint was defined as the occurrence of hemodynamically relevant VT/VF and/or adequate ICD-therapy during follow-up.
Endomyocardial biopsy detected cardiac fibrosis in 18 (32.1%) patients. Cardiac MRI revealed 35 (62.5%) patients with positive late gadolinium enhancement. VT/VF was induced in ten (17.9%) patients during programmed ventricular stimulation. Monomorphic VT was inducible in 70%, while 20% of patients showed polymorphic VT. One patient (10%) presented with VF. Inducibility correlated significantly with the presence of positive late gadolinium enhancement in cardiac MRI (p<0.01). We could not find a significant association between inducibility and the degree of cardiac inflammation and fibrosis in non-site directed routine right ventricular endomyocardial biopsy. During a mean follow-up of 2.6 years, nine (16.1%) patients reached the primary endpoint. Monomorphic VTs were found in 66.7% patients and were terminated by antitachycardia pacing therapy. One patient with polymorphic VT and two patients with VF received adequate therapy by an ICD-shock. However, inducibility did not correlate with the occurrence of endpoints.
Inducibilty during programmed ventricular stimulation is associated with positive late gadolinium enhancement in cardiac MRI of patients with non-ischemic dilated cardiomyopathy. The presence of myocardial fibrosis or inflammation in undirected endomyocardial biopsy does not seem to be sufficient to predict future ventricular arrhythmias.
在器械植入时代,非缺血性扩张型心肌病患者的危险分层仍是一个有争议的问题。
我们研究了组织病理学发现、对比增强心脏磁共振成像(MRI)与程序性心室刺激中室性心动过速(VT)或颤动(VF)的诱发性之间的关联。
对56例因非缺血性扩张型心肌病导致左心室射血分数受损(左心室射血分数≤50%,平均36.6±10.5%)的患者进行了心脏MRI、程序性心室刺激和心内膜活检,并进行回顾性研究。诱发性定义为持续的单形性或多形性VT或需要心脏复律/除颤的不稳定VT/VF。主要研究终点定义为随访期间发生血流动力学相关的VT/VF和/或适当的植入式心律转复除颤器(ICD)治疗。
心内膜活检在18例(32.1%)患者中检测到心脏纤维化。心脏MRI显示35例(62.5%)患者延迟钆增强阳性。在程序性心室刺激期间,10例(17.9%)患者诱发出VT/VF。70%的患者可诱发出单形性VT,而20%的患者表现为多形性VT。1例患者(10%)出现VF。诱发性与心脏MRI延迟钆增强阳性显著相关(p<0.01)。在非定向常规右心室心内膜活检中,我们未发现诱发性与心脏炎症和纤维化程度之间存在显著关联。在平均2.6年的随访期间,9例(16.1%)患者达到主要终点。66.7%的患者发现单形性VT,并通过抗心动过速起搏治疗终止。1例多形性VT患者和2例VF患者通过ICD电击接受了适当治疗。然而,诱发性与终点事件的发生无关。
在非缺血性扩张型心肌病患者的心脏MRI中,程序性心室刺激期间的诱发性与延迟钆增强阳性相关。非定向心内膜活检中存在心肌纤维化或炎症似乎不足以预测未来的室性心律失常。